A multinational research team led by Columbia University and the La Jolla Institute for Immunology has identified a novel viral target that could help combat the global resurgence of measles.
A new study shows that an ancient mechanism of regulating a cell’s protein repertoire allows malaria parasites to hide from fast-acting artemisinin drugs and survive.
A nasal spray created by Columbia researchers prevented transmission of SARS-CoV-2 in ferrets, suggesting the spray could also prevent transmission of the coronavirus in people.
Since the beginning of the pandemic, more than 120 million people in the United States may have been infected by SARS-CoV-2, according to researchers at the Mailman School of Public Health.
Pregnant women face greater risks to their health from COVID-19 than the general population and should be offered a vaccine if eligible, say experts at Columbia and NewYork-Presbyterian.
Cancer patients on active treatment are 35% less likely to develop COVID-19 than patients not receiving treatment, though those who did test positive for SARS-CoV-2 experienced higher death rates.
Prioritizing older New Yorkers for COVID vaccines and delaying second doses could reduce hospitalizations and deaths, according to new modeling projections from Mailman epidemiologists.
Millions more Americans will be infected with SARS-CoV-2 and become ill with COVID-19 if policies to enforce physical distancing are lifted prematurely, Mailman epidemiologists say.
Mailman experts and other policymakers discuss measures that should be deployed during vaccine rollout to reduce inequities, already worsened by the pandemic, in the U.S. and globally.